Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$1.12 - $1.57 $313 - $439
-280 Reduced 0.34%
81,604 $120,000
Q3 2023

Nov 08, 2023

BUY
$1.07 - $1.39 $299 - $389
280 Added 0.34%
81,884 $88,000
Q2 2022

Aug 05, 2022

BUY
$0.67 - $3.19 $6 - $31
10 Added 0.01%
81,604 $92,000
Q1 2020

May 05, 2020

SELL
$1.27 - $3.0 $431 - $1,020
-340 Reduced 0.41%
81,594 $127,000
Q3 2017

Oct 31, 2017

BUY
$2.18 - $2.57 $178,616 - $210,570
81,934
81,934 $208,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.